Recombinant Human GDF7 Protein: Research Guide

Recombinant Human GDF7 Protein is a research-grade cytokine belonging to the bone morphogenetic protein (BMP) subfamily of the TGF-β superfamily, produced for use in studies of tendon and ligament differentiation, neuronal development, and related signaling pathways.

Also Known As

GDF7, BMP12, Growth Differentiation Factor 7

Protein Family

TGF-β superfamily, BMP subfamily

Primary Applications

Tendon/ligament differentiation, neuronal differentiation, cell signaling studies

SKU

rp369352

Source

Recombinant, expressed in a heterologous host system

Supplier Reference

absea#PQ-4734

What Is GDF7 and Why Does It Matter?

Growth Differentiation Factor 7 (GDF7), also designated BMP12, is a secreted signaling protein that belongs to the bone morphogenetic protein (BMP) subfamily within the broader TGF-β superfamily. Like other BMP family members, GDF7 signals through hetero- or homodimeric type I and type II serine/threonine kinase receptors, activating downstream SMAD-dependent and SMAD-independent pathways to regulate gene expression.

GDF7 is notable for its well-documented role in the differentiation of tendon and ligament progenitor cells. Studies in developmental biology have demonstrated that GDF7 (together with GDF5 and GDF6) contributes to the specification and maintenance of tendon and ligament tissues. Additionally, GDF7 has been implicated in the development of specific neuronal populations in the dorsal spinal cord, highlighting its broader importance in tissue patterning and organogenesis.

For researchers working in musculoskeletal biology, regenerative medicine, or developmental neuroscience, Recombinant Human GDF7 Protein provides a reliable exogenous source of this cytokine to modulate cell behavior in vitro and to dissect signaling mechanisms.

Protein Specifications and Quality Considerations

Recombinant Human GDF7 Protein (SKU: rp369352) is manufactured as a research-grade reagent. When evaluating recombinant cytokines such as GDF7, researchers should consider the following key quality attributes:

• Purity: High-purity preparations (typically >95% by SDS-PAGE or HPLC) are recommended for cell-based assays to minimize confounding effects from host-cell protein contaminants.
• Biological Activity: Activity is commonly assessed by the ability of the protein to induce alkaline phosphatase expression in appropriate cell lines or to promote tenogenic marker expression in mesenchymal progenitors. Users should consult the product-specific Certificate of Analysis (CoA) for lot-specific activity data.
• Endotoxin Level: For cell culture applications, low endotoxin levels (typically <1 EU/µg) are critical to avoid non-specific inflammatory responses.
• Formulation: The protein is typically supplied lyophilized or in a carrier protein-containing buffer. Refer to the specific lot CoA for exact formulation details.

Note: Exact numerical specifications (molecular weight, specific activity values, endotoxin thresholds) for SKU rp369352 should be confirmed against the current product datasheet and Certificate of Analysis available from Aladdin Scientific.

Reconstitution and Storage Protocol

Proper reconstitution and storage are essential to preserve the biological activity of Recombinant Human GDF7 Protein. The following guidelines represent standard best practices for lyophilized recombinant BMP-family proteins; always cross-reference with the product-specific datasheet:

1. Reconstitution: Allow the lyophilized vial to equilibrate to room temperature before opening. Reconstitute in sterile, distilled water or PBS (pH 7.4) to a stock concentration typically in the range of 0.1–1.0 mg/mL. For cell culture use, carrier protein (e.g., 0.1% BSA in PBS) is recommended to improve stability and reduce adsorption to tube surfaces.
2. Mixing: Gently swirl or pipette to dissolve; avoid vigorous vortexing, which can cause protein denaturation.
3. Aliquoting: Prepare single-use aliquots to avoid repeated freeze-thaw cycles, which degrade protein integrity and reduce biological activity.
4. Storage: Store lyophilized protein at –20 °C or –80 °C. Reconstituted protein should be stored at –80 °C for long-term use or at 4 °C for short-term use (typically up to 1 week). Avoid multiple freeze-thaw cycles (recommended maximum: 3 cycles).
5. Sterility: Use aseptic technique throughout to prevent microbial contamination of cell culture reagents.

Always consult the current product datasheet for lot-specific reconstitution volumes and storage recommendations.

Research Applications of Recombinant Human GDF7

Recombinant Human GDF7 Protein is employed across a range of research contexts, leveraging its role as a developmental signaling molecule:

• Tendon and Ligament Differentiation: GDF7 is used to induce tenogenic differentiation in mesenchymal stem cells (MSCs) and fibroblast populations in vitro, supporting research into tendon repair and regenerative medicine strategies.
• Neuronal Development Studies: GDF7 has been shown to play a role in the specification of commissural interneurons in the dorsal spinal cord. Researchers use recombinant GDF7 to model aspects of spinal cord development and to investigate BMP signaling in neural progenitor differentiation.
• BMP Signaling Pathway Research: As a BMP subfamily member, GDF7 is used to activate and study SMAD1/5/8-mediated signaling cascades, contributing to understanding of BMP receptor specificity and downstream gene regulation.
• Receptor Binding and Interaction Studies: Recombinant GDF7 can be used in binding assays to characterize receptor affinity and selectivity (e.g., BMPR-IA, BMPR-IB, BMPR-II).
• Drug Discovery and Target Validation: GDF7's restricted expression pattern and defined biological roles make it a candidate target for musculoskeletal and neurological disease research, and recombinant protein is used in screening assays.

Handling Tips and Troubleshooting

To maximize experimental reproducibility and protein performance, consider the following practical guidance:

• Low Activity Signal: If observed biological activity is lower than expected, verify reconstitution procedure, check for protein degradation (run an SDS-PAGE), confirm that the bioassay cell line is responsive to BMP/GDF stimulation, and ensure endotoxin levels are not confounding results.
• Protein Aggregation: Aggregation can reduce apparent activity. If turbidity is observed after reconstitution, centrifuge briefly (e.g., 10,000 × g for 5 minutes at 4 °C) and use the supernatant. Adding carrier protein (BSA) during reconstitution reduces aggregation tendency.
• Dose-Response Optimization: Optimal effective concentrations vary by cell type and assay format. It is recommended to perform a dose-response experiment (e.g., 1–500 ng/mL range) to determine the ED50 for your specific system.
• Non-Specific Effects: At supraphysiological concentrations, GDF7 may activate non-canonical pathways. Use concentrations validated in peer-reviewed literature as a starting point.
• Contamination Control: Always include vehicle controls and negative controls in cell-based assays to account for solvent or carrier protein effects.

Frequently asked questions

What is the difference between GDF7 and BMP12?

GDF7 and BMP12 refer to the same protein. BMP12 is an alternative nomenclature used in earlier literature, while GDF7 (Growth Differentiation Factor 7) is the current, preferred HGNC-approved gene and protein name. Both names describe the identical human protein encoded by the GDF7 gene.

What cell types are most commonly used to assess GDF7 biological activity?

GDF7 biological activity is commonly assessed using mesenchymal stem cells (MSCs) or tendon-derived fibroblasts, where it promotes expression of tenogenic markers such as tenomodulin and scleraxis. Alkaline phosphatase induction assays in osteoblast-lineage cell lines (e.g., C2C12 or W20-17 cells) are also used as a surrogate readout for BMP-family activity, though specificity should be verified for GDF7.

How many freeze-thaw cycles can Recombinant Human GDF7 Protein tolerate?

As a general guideline for recombinant BMP-family proteins, it is recommended to limit freeze-thaw cycles to a maximum of three to preserve protein integrity and biological activity. Single-use aliquots prepared at the time of reconstitution are strongly advised. Please refer to the specific product datasheet for lot-verified stability data.

Is Recombinant Human GDF7 Protein suitable for in vivo animal studies?

Recombinant Human GDF7 Protein (rp369352) is supplied as a research-use-only reagent and is not approved for clinical or therapeutic use. Suitability for in vivo studies depends on the specific formulation, endotoxin level, and purity of the lot. Researchers planning in vivo experiments should confirm these parameters with Aladdin Scientific and consult applicable institutional and regulatory guidelines.

What receptors does GDF7 signal through?

GDF7, as a BMP subfamily member, signals primarily through type I receptors (including BMPR-IA/ALK3 and BMPR-IB/ALK6) and type II receptors (BMPR-II, ActRIIA, ActRIIB), leading to phosphorylation of receptor-regulated SMADs (R-SMADs 1, 5, and 8) and activation of downstream target genes. Receptor binding affinity and selectivity may differ from other BMP ligands and should be verified in the experimental model of interest.

References

1. Wolfman NM, et al. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. Journal of Clinical Investigation. 1997;100(2):321-330. PMID:9218507
2. Liem KF Jr, et al. A role for BMP proteins as intercellular signals that pattern the dorsal spinal cord. Cell. 2000;100(4):423-435. PMID:10693759
3. Ye M, et al. BMP signaling in tendon biology. Developmental Cell. (General reference — specific volume/page needs verification).

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.